CN104587402A - 一种治疗慢性盆腔炎的中药制剂及其制备方法 - Google Patents
一种治疗慢性盆腔炎的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104587402A CN104587402A CN201510043512.0A CN201510043512A CN104587402A CN 104587402 A CN104587402 A CN 104587402A CN 201510043512 A CN201510043512 A CN 201510043512A CN 104587402 A CN104587402 A CN 104587402A
- Authority
- CN
- China
- Prior art keywords
- herba
- rhizoma
- chinese medicine
- water
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title abstract description 21
- 230000001684 chronic effect Effects 0.000 title abstract description 12
- 241000792859 Enema Species 0.000 claims abstract description 20
- 239000007920 enema Substances 0.000 claims abstract description 20
- 229940095399 enema Drugs 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000002893 slag Substances 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 230000008719 thickening Effects 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 32
- 231100000331 toxic Toxicity 0.000 abstract description 7
- 230000002588 toxic effect Effects 0.000 abstract description 7
- 240000009138 Curcuma zedoaria Species 0.000 abstract description 2
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract description 2
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract description 2
- 235000019509 white turmeric Nutrition 0.000 abstract description 2
- 235000016811 Biondella Nutrition 0.000 abstract 1
- 241000233838 Commelina Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 244000137773 Viola philippica Species 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 231100000111 LD50 Toxicity 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 238000002604 ultrasonography Methods 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010003011 Appendicitis Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 241000521257 Hydrops Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 4
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010000210 abortion Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 241000233945 Typhaceae Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 206010034260 pelvic mass Diseases 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 206010016029 Face oedema Diseases 0.000 description 1
- 241001293752 Gentiana manshurica Species 0.000 description 1
- 241000486199 Gentiana rigescens Species 0.000 description 1
- 241000555675 Gentiana triflora Species 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000186366 Mycobacterium bovis Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 241000501113 Sargentodoxa cuneata Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000510764 Villosa Species 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 150000003836 berberines Chemical group 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 229940015507 dexamethasone 0.75 mg Drugs 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
试验号 | A | B | C | 小檗碱转移率(%) | 巴马汀转移率(%) |
1 | 1 | 1 | 2 | 76.36 | 75.23 |
2 | 2 | 2 | 3 | 50.46 | 51.35 |
3 | 3 | 3 | 1 | 66.72 | 68.35 |
4 | 4 | 1 | 3 | 62.88 | 64.26 |
5 | 5 | 2 | 1 | 71.30 | 70.18 |
6 | 6 | 3 | 2 | 76.28 | 76.89 |
组别 | 例数(例) | 痊愈 | 显效 | 好转 | 无效 | 总有效率 |
本发明组 | 80 | 66.2% | 28.8% | 5.0% | 0 | 100.0% |
对照组 | 80 | 57.5% | 26.2% | 10.0% | 6.3% | 93.7% |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510043512.0A CN104587402B (zh) | 2015-01-29 | 2015-01-29 | 一种治疗慢性盆腔炎的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510043512.0A CN104587402B (zh) | 2015-01-29 | 2015-01-29 | 一种治疗慢性盆腔炎的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104587402A true CN104587402A (zh) | 2015-05-06 |
CN104587402B CN104587402B (zh) | 2016-01-20 |
Family
ID=53113673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510043512.0A Expired - Fee Related CN104587402B (zh) | 2015-01-29 | 2015-01-29 | 一种治疗慢性盆腔炎的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104587402B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770625A (zh) * | 2016-04-24 | 2016-07-20 | 张昌莲 | 一种治疗盆腔炎的中药组合物 |
CN107041932A (zh) * | 2017-03-24 | 2017-08-15 | 柳州市妇幼保健院 | 一种用于治疗盆腔炎的中药制剂及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103800843A (zh) * | 2014-03-18 | 2014-05-21 | 黄淑娟 | 一种治疗慢性盆腔炎的中药组合物 |
-
2015
- 2015-01-29 CN CN201510043512.0A patent/CN104587402B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103800843A (zh) * | 2014-03-18 | 2014-05-21 | 黄淑娟 | 一种治疗慢性盆腔炎的中药组合物 |
Non-Patent Citations (4)
Title |
---|
杨敏等: "《中华妇产科护理"三基"训练》", 31 July 2006, article "《慢性盆腔炎》", pages: 398 * |
王磊: "《妇科病中西医结合治疗》", 31 July 2011, article "《中药煎剂保留灌肠治疗慢性盆腔炎》", pages: 132 * |
金燕娜: "《中药保留灌肠治疗慢性盆腔炎40例》", 《浙江中西医结合杂志》, vol. 19, no. 8, 31 December 2009 (2009-12-31), pages 497 - 498 * |
钱忆: "《红藤五物汤灌肠治疗慢性盆腔炎90例》", 《江苏中医》, vol. 19, no. 4, 31 December 1998 (1998-12-31), pages 21 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770625A (zh) * | 2016-04-24 | 2016-07-20 | 张昌莲 | 一种治疗盆腔炎的中药组合物 |
CN107041932A (zh) * | 2017-03-24 | 2017-08-15 | 柳州市妇幼保健院 | 一种用于治疗盆腔炎的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104587402B (zh) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103721131A (zh) | 一种治疗妇女慢性盆腔炎的中药栓剂及其制备方法 | |
CN101537107A (zh) | 有效治疗皮肤真菌病的外用擦剂及其制备方法 | |
CN104274788A (zh) | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN102018807A (zh) | 一种治疗妇科滴虫性阴道炎的药物组合物及其制备方法 | |
CN104306498B (zh) | 一种治疗妇女肾虚寒湿型带下的中药组合物及其制备方法 | |
CN104587402B (zh) | 一种治疗慢性盆腔炎的中药制剂及其制备方法 | |
CN102847021A (zh) | 一种治疗溃疡性结肠炎的灌肠剂及其制备方法 | |
CN102631641A (zh) | 一种治疗盆腔炎的灌肠液 | |
CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
CN103933393A (zh) | 一种治疗化脓性关节炎的中药及制备方法 | |
CN103120760A (zh) | 用于治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN104147516A (zh) | 一种治疗骨髓炎的中药组方 | |
CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
CN102631590B (zh) | 一种治疗暑湿型结肠炎的中药制备方法 | |
CN104971271A (zh) | 一种治疗瘀湿化热型前列腺增生的药物及制备方法 | |
CN105056201A (zh) | 一种治疗浆细胞性乳腺炎的中药制剂及其制备方法 | |
CN104352910A (zh) | 一种治疗妇女带下的中药外用栓剂及其制备方法 | |
CN104127774A (zh) | 一种用于治疗皮肤癣的药剂及其制备方法 | |
CN104096103A (zh) | 一种治疗癃闭的中药药剂 | |
CN103054996B (zh) | 治疗湿热型骨关节炎的中药及其制备方法 | |
CN103054991A (zh) | 一种治疗少腹部不适的中药组合物及其制备方法和用途 | |
CN103735920B (zh) | 一种治疗半身不遂的药物及其制备方法 | |
CN102988847A (zh) | 一种治疗阴道炎的药物组合物 | |
CN104338086A (zh) | 一种治疗慢性子宫内膜炎的中药灌肠剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151111 Address after: 315200 Zhejiang Industrial Zone, Ningbo Free Trade Zone, No. 5, building 5, building 509, room 1 Applicant after: Ningbo Free Trade Zone Xinnuo Biotechnology Co., Ltd. Address before: 315200 Zhejiang city of Ningbo Province Liu Zhuang Anchen rhyme 42 room 1202 Applicant before: Wu Jun |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Zhiqiang Inventor before: Wu Jun Inventor before: Ding Pingyue Inventor before: Zhang Yaqiong Inventor before: Zhang Jiajia Inventor before: Wang Zhonghua |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171009 Address after: 056000 Hebei city of Handan province Fengfeng mine new urban Gushan No. 4 South Street No. 6 Building 2 unit 10 Patentee after: Li Zhiqiang Address before: 315200 Zhejiang Industrial Zone, Ningbo Free Trade Zone, No. 5, building 5, building 509, room 1 Patentee before: Ningbo Free Trade Zone Xinnuo Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160120 Termination date: 20180129 |
|
CF01 | Termination of patent right due to non-payment of annual fee |